Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studies
Article in Saudi Pharmaceutical Journal (August 2023)
The most recent citing publications are shown below. View all 59 publications that cite this research output on Dimensions.
LOXL1-AS1 Contributes to Non-Small Cell Lung Cancer Progression by Regulating miR-3128/RHOXF2 Axis
Article in OncoTargets and Therapy (June 2020)
Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway.
Article in American Journal of Translational Research (May 2020)